TR201902845T4 - Artritik durumların karakterize edilmesine yönelik bileşimler ve yöntemler. - Google Patents

Artritik durumların karakterize edilmesine yönelik bileşimler ve yöntemler. Download PDF

Info

Publication number
TR201902845T4
TR201902845T4 TR2019/02845T TR201902845T TR201902845T4 TR 201902845 T4 TR201902845 T4 TR 201902845T4 TR 2019/02845 T TR2019/02845 T TR 2019/02845T TR 201902845 T TR201902845 T TR 201902845T TR 201902845 T4 TR201902845 T4 TR 201902845T4
Authority
TR
Turkey
Prior art keywords
compositions
methods
arthritic conditions
characterizing
characterizing arthritic
Prior art date
Application number
TR2019/02845T
Other languages
English (en)
Inventor
Marotta Anthony
Original Assignee
Augurex Life Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Augurex Life Sciences Corp filed Critical Augurex Life Sciences Corp
Publication of TR201902845T4 publication Critical patent/TR201902845T4/tr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Mevcut buluş, 14-3-3 proteinlerine karşı otoantikorlar veya bunların dolaşan immün kompleksleri ve bir artritik durumun teşhisi ve prognozuna yönelik bunların saptanması ile ilgilidir.
TR2019/02845T 2009-03-11 2010-03-11 Artritik durumların karakterize edilmesine yönelik bileşimler ve yöntemler. TR201902845T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15938609P 2009-03-11 2009-03-11

Publications (1)

Publication Number Publication Date
TR201902845T4 true TR201902845T4 (tr) 2019-03-21

Family

ID=42727761

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/02845T TR201902845T4 (tr) 2009-03-11 2010-03-11 Artritik durumların karakterize edilmesine yönelik bileşimler ve yöntemler.

Country Status (16)

Country Link
US (2) US11054419B2 (tr)
EP (1) EP2406633B1 (tr)
JP (1) JP5792637B2 (tr)
KR (1) KR101894597B1 (tr)
CN (1) CN102414563B (tr)
AU (1) AU2010223776B2 (tr)
BR (1) BRPI1009573A2 (tr)
CA (1) CA2754741C (tr)
DK (1) DK2406633T3 (tr)
ES (1) ES2714216T3 (tr)
HU (1) HUE043684T2 (tr)
IL (1) IL215056A (tr)
PL (1) PL2406633T3 (tr)
PT (1) PT2406633T (tr)
TR (1) TR201902845T4 (tr)
WO (1) WO2010102412A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012325604B2 (en) * 2011-10-21 2017-08-03 Augurex Life Sciences Corp. Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
CN108344865A (zh) * 2018-01-05 2018-07-31 北京科美生物技术有限公司 检测14-3-3eta蛋白的均相免疫检测试剂盒及其应用
IL278616B2 (en) * 2018-05-10 2025-02-01 Methodist Hospital Methods for the prognosis and treatment management of a disease
CN110531073B (zh) * 2018-05-23 2024-03-15 科美诊断技术股份有限公司 通过生物标记物联检体外评估类风湿性关节炎是否存在的方法
CN110579600B (zh) * 2018-05-23 2023-12-26 科美诊断技术股份有限公司 通过生物标记物联检体外评估类风湿性关节炎是否存在的方法
CN110579597A (zh) * 2018-05-23 2019-12-17 科美诊断技术股份有限公司 检测14-3-3 eta蛋白的非均相化学发光免疫检测试剂盒及其应用
CN110579601B (zh) * 2018-05-24 2023-12-26 科美诊断技术股份有限公司 通过生物标记物联检体外评估类风湿性关节炎是否存在的方法
CN110726843A (zh) * 2018-07-16 2020-01-24 科美诊断技术股份有限公司 检测14-3-3eta蛋白的化学发光免疫检测试剂盒及其应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956281A (en) * 1987-06-03 1990-09-11 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3
US6596476B1 (en) * 1989-12-22 2003-07-22 Abbott Laboratories Hepatitis C assay
US5948765A (en) 1996-03-15 1999-09-07 Washington University Inhibition of intracellular signal transduction by 14-3-3-binding peptides
US5998149A (en) 1996-04-05 1999-12-07 The United States Of America As Represented By The Department Of Health And Human Services Method of detecting transmissible spongiform encephalopathies
US5814507A (en) 1996-05-24 1998-09-29 Genentech, Inc. κ/μ-like protein tyrosine phosphatase, PTP λ
AU5601298A (en) 1996-12-12 1998-07-03 Neuromark Methods of detecting transmissible spongiform encephalopathies by detecting 14-3-3 protein isoforms
US20020173454A1 (en) * 2000-01-31 2002-11-21 Rosen Craig A. Nucleic acids, proteins, and antibodies
US7011952B2 (en) * 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
WO2001070805A2 (en) 2000-03-17 2001-09-27 Gemini Science, Inc. Soluble mast cell function associated antigen (mafa) pharmaceutical compositions and methods of making and using them
KR100380147B1 (ko) 2001-01-18 2003-04-11 주식회사 엘지생명과학 류마티스성 자가면역 항체의 검출방법 및 검출키트
US7335635B2 (en) 2001-02-21 2008-02-26 Emory University 14-3-3 binding molecules as sensitizers for anticancer therapies
JP3806694B2 (ja) * 2001-05-04 2006-08-09 バイオサイト インコーポレイテッド 急性冠状動脈症候群の診断マーカーおよびその使用方法
DE10131912A1 (de) 2001-06-06 2002-12-19 Werner E G Mueller Verwendung von 14-3-3 Proteinen und Verfahren zu deren Bestimmung
US7171311B2 (en) 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
US7172905B2 (en) * 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
GB0208331D0 (en) 2002-04-11 2002-05-22 Oxford Glycosciences Uk Ltd Proteins
US7101962B2 (en) 2003-05-15 2006-09-05 Bristol-Myers Squibb Company Antibodies of the P2Y10 receptor useful in altering T lymphocyte function
AU2004249814A1 (en) 2003-06-25 2004-12-29 Queen's University At Kingston Methods for diagnosing, monitoring, staging and treating heart failure
AU2004294933B2 (en) 2003-11-21 2011-11-17 Johns Hopkins University Biomolecule partition motifs and uses thereof
TWI281473B (en) * 2003-12-19 2007-05-21 Ind Tech Res Inst Biomarkers for liver diseases and method for using same
AU2005238446B2 (en) 2004-04-15 2009-07-30 Banyan Biomarkers Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
US20070253961A1 (en) 2004-06-09 2007-11-01 Ulsan Industrial Education Foundation Pharmaceutical Composition Comprising the Anti-4-1Bb Antibody for Treating or Preventing Rheumatoid Arthritis
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
GB2428240A (en) 2005-07-14 2007-01-24 Univ Gen Ve Diagnostic method for brain damage-related disorders
PT2021792E (pt) * 2006-05-09 2013-05-23 Univ British Columbia Marcadores proteicos dissolvidos para artrite
CA2694154A1 (en) 2007-10-03 2009-04-09 Osi Pharmaceuticals, Inc. Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
WO2009046267A1 (en) 2007-10-05 2009-04-09 University Of Virginia Patent Foundation Protein-based biomarkers for abdominal aortic aneurysm
US7919262B2 (en) 2007-11-07 2011-04-05 The Uab Research Foundation 14-3-3 proteins for diagnosis of Parkinson's disease
US20110027269A1 (en) * 2007-11-27 2011-02-03 The Unversity of British Office 14-3-3 Antagonists for the Prevention and Treatment of Arthritis
WO2009097584A1 (en) 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
WO2009137832A2 (en) * 2008-05-09 2009-11-12 Duke University Autoantibodies in the detection and treatment of cancer
MX2012014268A (es) 2010-07-09 2013-02-12 Somalogic Inc Biomarcadores de cancer de pulmon y usos de los mismos.
CN103429753A (zh) 2010-09-27 2013-12-04 私募蛋白质体公司 间皮瘤生物标记及其用途

Also Published As

Publication number Publication date
US11054419B2 (en) 2021-07-06
EP2406633A1 (en) 2012-01-18
EP2406633A4 (en) 2012-08-29
CN102414563B (zh) 2014-12-03
CA2754741A1 (en) 2010-09-16
IL215056A (en) 2015-10-29
CA2754741C (en) 2019-02-12
US20210333276A1 (en) 2021-10-28
AU2010223776A1 (en) 2011-10-20
WO2010102412A1 (en) 2010-09-16
KR101894597B1 (ko) 2018-10-04
JP2012519860A (ja) 2012-08-30
CN102414563A (zh) 2012-04-11
PT2406633T (pt) 2019-03-14
KR20120004990A (ko) 2012-01-13
JP5792637B2 (ja) 2015-10-14
AU2010223776B2 (en) 2016-08-25
ES2714216T3 (es) 2019-05-27
PL2406633T3 (pl) 2019-07-31
EP2406633B1 (en) 2019-01-16
HUE043684T2 (hu) 2019-09-30
IL215056A0 (en) 2011-11-30
US20120058498A1 (en) 2012-03-08
BRPI1009573A2 (pt) 2017-07-18
DK2406633T3 (en) 2019-04-01

Similar Documents

Publication Publication Date Title
CY1122676T1 (el) Αντισωματα εναντι της κλαυδινης 18.2 που ειναι χρησιμα στη διαγνωση του καρκινου
CY1117784T1 (el) Μεθοδοι και συνθεσεις για διαγνωση και προγνωση νεφρικης βλαβης και νεφρικης ανεπαρκειας
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
HK1214652A1 (zh) 用於检测胰腺癌的方法和组合物
EP2577300A4 (en) MULTIFUNCTIONAL PARTICLE SCANNING
EA201591740A1 (ru) Вирусы болезни ньюкасла и их применение
EA201590247A1 (ru) Антитела к siglec-15
GB201308243D0 (en) High-throughput immune sequencing
EA201491541A1 (ru) АНТИТЕЛА ПРОТИВ ИНТЕГРИНОВ αvβ6 И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННЫХ НОВООБРАЗОВАНИЙ
EA201390149A1 (ru) Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток
EP3734280A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011088385A3 (en) Compositions and methods for detecting cancer
EA201400117A1 (ru) Способы и нуклеиновые кислоты для определения прогноза у больных раком
EA201201000A1 (ru) Способы лечения колоректального рака
BR112014012590A8 (pt) Anticorpos anti-cd98 e métodos de uso dos mesmos
HK1200037A1 (en) Non-invasive methods of detecting target molecules
MY170983A (en) Biomarker assays for detecting or measuring inhibition of tor kinase activity
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EA201390638A8 (ru) Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения
MX2023012628A (es) Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales.
WO2015070001A3 (en) Compositions and methods for detecting and/or treating inflammation
MX2012001559A (es) Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal.
EA201891002A1 (ru) Иммунологический анализ для определения расщепленного высокомолекулярного кининогена
MX2014000283A (es) Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal.
BRPI1009573A2 (pt) método para avaliar uma condição artrítica em um sujeito, kit para detectar a presença de um auto-anticorpo, e, método para determinar o subtipo de artrite em um paciente.